Literature DB >> 8528550

Reduction by NG-nitro-L-arginine methyl ester (L-NAME) of antigen-induced nasal airway plasma extravasation in human subjects in vivo.

J W Dear1, G K Scadding, J C Foreman.   

Abstract

In non-allergic subjects, histamine induced a reduction of minimal nasal cross-sectional area (Amin) and an increase in albumin release into nasal lavage. The effect of histamine on albumin release was inhibited by pretreatment with NG-nitro-L-arginine methyl ester (L-NAME), 1 mumol but not by D-NAME, 1 mumol. L-NAME, 1 and 10 mumol, did not inhibit the histamine-induced reduction of Amin. In subjects allergic to grass pollen, antigen challenge induced a reduction in Amin that was not changed by pretreatment with L-NAME, and an increase in albumin release that was inhibited by L-NAME, 1 mumol. The data support a role for nitric oxide in mediating plasma extravasation in the nose induced by antigen challenge or histamine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528550      PMCID: PMC1909081          DOI: 10.1111/j.1476-5381.1995.tb16653.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

Review 1.  The nasal allergic reaction: observations on the role of histamine.

Authors:  R M Naclerio; A G Togias
Journal:  Clin Exp Allergy       Date:  1991-05       Impact factor: 5.018

Review 2.  Biology and clinical relevance of nitric oxide.

Authors:  P Vallance; J Collier
Journal:  BMJ       Date:  1994-08-13

3.  Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency.

Authors:  C E Austin; J C Foreman
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

4.  Mediator release after nasal airway challenge with allergen.

Authors:  R M Naclerio; H L Meier; A Kagey-Sobotka; N F Adkinson; D A Meyers; P S Norman; L M Lichtenstein
Journal:  Am Rev Respir Dis       Date:  1983-10

5.  Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor.

Authors:  H R Knapp
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

6.  High nitric oxide production in human paranasal sinuses.

Authors:  J O Lundberg; T Farkas-Szallasi; E Weitzberg; J Rinder; J Lidholm; A Anggåard; T Hökfelt; J M Lundberg; K Alving
Journal:  Nat Med       Date:  1995-04       Impact factor: 53.440

7.  Effect of terfenadine and placebo on symptoms after nasal allergen provocation.

Authors:  H K Rökenes; B Andersson; H Rundcrantz
Journal:  Clin Allergy       Date:  1988-01

8.  Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.

Authors:  D Proud; A Togias; R M Naclerio; S A Crush; P S Norman; L M Lichtenstein
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Mechanisms of histamine-induced coronary vasodilatation: H1-receptor-mediated release of endothelium-derived nitric oxide.

Authors:  M Kelm; M Feelisch; T Krebber; W Motz; B E Strauer
Journal:  J Vasc Res       Date:  1993 May-Jun       Impact factor: 1.934

10.  Neuronal nitric oxide synthase is localized in extrinsic nerves regulating perireceptor processes in the chemosensory nasal mucosae of rats and humans.

Authors:  A P Kulkarni; T V Getchell; M L Getchell
Journal:  J Comp Neurol       Date:  1994-07-01       Impact factor: 3.215

  10 in total
  1 in total

1.  Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway.

Authors:  P J Turner; J R Maggs; J C Foreman
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.